From Gene Discovery to Patient Impact: A Conversation with Susan A. Slaugenhaupt, PhD

Susan A. Slaugenhaupt, PhD, investigator at Mass General Brigham and president of the American Society for Human Genetics, reflects on more than 30 years of genetics research, from identifying genes linked to rare diseases to advancing new therapies for patients. She discusses breakthroughs in genomics, the future of precision medicine, and how patients and families continue to inspire her work.

Read More

Online Platform Accelerates Rare Disease Research

Earlier this week, the Mass General Neurological Clinical Research Center (NCRI)’s  NeuroBANK™ won Bio-IT World‘s Best Practice award in the Personalized & Translational Medicine category. What is the NeuroBANK, and how is it helping to accelerate the discovery, development, and delivery of future treatments for rare diseases including amyotrophic lateral sclerosis (ALS)? Filling a Need…

Read More